Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...

Medtronic plc MDT recently announced the first successful patient procedure with the Hugo robotic-assisted surgery (RAS) system. The robot-assisted prostatectomy was performed at Clínica Santa María ...

Embrace Gynecology becomes the third IDE clinical study for Hugo RAS in the U.S., demonstrating Medtronic’s commitment to ...

Medtronic plc MDT recently announced the integration of its Hugo robotic-assisted surgery (RAS) system at Hospital Clinico de la Red de Salud UC CHRISTUS in Santiago, Chile, to support the teaching ...

Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral ...

Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S.

The medical device maker is rolling out a new robotic surgery system to boost flagging revenue growth. The Hugo system's modular approach may help it compete with dominant rival Intuitive Surgical.